Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Chungnam University Partner on Glycomics

NEW YORK (GenomeWeb News) – Agilent and Chungnam National University today announced a collaboration targeting glycomics.

Under the terms of the deal, the partners will develop new applications, methods, technologies, and software tools for glycan analysis. The South Korean university hopes to identify and develop biomarkers for diseases, such as cancer, resulting in the development of therapeutic antibody products.

The partnership is Agilent's first with an Asian university, the partners said.

"The knowledge gleaned from the collaboration will not only contribute toward the improvement of the biosimilars industry in Korea, but also help scientists discover new cures and develop new drugs and vaccines to treat and prevent diseases," Rod Minett, general manager of Agilent Life Sciences Group, South Asia Pacific and Korea, said in a statement.

Financial and other terms were not disclosed.

The research will be jointly led by Hyun Joo An and Rudolf Grimm. An is a professor in the department of analytical science and technology at Chungnam National University's Graduate School of Analytical Science and Technology, or GRAST, and head of the new Asia Glycomics Education Center.

Grimm is Agilent's director of science and technology and manager of collaborations in the Asia Pacific region, as well as an adjunct professor at Chungnam National University.

The agreement also calls for GRAST to develop glycomics training courses for Agilent's customers and employees. Agilent will use GRAST as a strategic glycomics reference site in Korea and Southeast Asia.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.